Ifp Advisors, Inc Oncotelic Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

  • $2.42 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 06, 2021
SELL
$0.1 - $0.18 $6,119 - $11,015
-61,196 Closed
0 $0
Q2 2021

Jul 13, 2021
BUY
$0.22 - $0.33 $13,463 - $20,194
61,196 New
61,196 $12,000

About Oncotelic Therapeutics, Inc.

OTLC Quotes by TradingView
  • Ticker OTLC
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 385,723,008
  • Market Cap $11.6M
  • Description
  • Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatme...
More about OTLC
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email